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Abstract: Aspartame is a phenylalanine containing sweetener, added to foods and drinks, which is 
avoided in phenylketonuria (PKU). However, the amount of phenylalanine provided by aspartame 
is unidentifiable from food and drinks labels. We performed a cross-sectional online survey aiming 
to examine the accidental aspartame consumption in PKU. 206 questionnaires (58% female) were 
completed. 55% of respondents (n = 114) were adults with PKU or their parent/carers and 45% (n = 
92) were parents/carers of children with PKU. 74% (n = 152/206) had consumed food/drinks contain-
ing aspartame. Repeated accidental aspartame consumption was common and more frequent in 
children (p < 0.0001). The aspartame containing food/drinks accidentally consumed were fizzy 
drinks (68%, n = 103/152), fruit squash (40%, n = 61/152), chewing gum (30%, n = 46/152), flavoured 
water (25%, n = 38/152), ready to drink fruit squash cartons (23%, n = 35/152) and sports drinks (21%, 
n = 32/152). The main reasons described for accidental consumption, were manufacturers’ changing 
recipes (81%, n = 123/152), inability to check the ingredients in pubs/restaurants/vending machines 
(59%, n = 89/152) or forgetting to check the label (32%, n = 49/152). 23% (n= 48/206) had been pre-
scribed medicines containing aspartame and 75% (n = 36/48) said that medicines were not checked 
by medics when prescribed. 85% (n = 164/192) considered the sugar tax made accidental aspartame 
consumption more likely. Some of the difficulties for patients were aspartame identification in 
drinks consumed in restaurants, pubs, vending machines (77%, n = 158/206); similarities in appear-
ance of aspartame and non-aspartame products (62%, n = 127/206); time consuming shop-
ping/checking labels (56%, n = 115/206); and unclear labelling (55%, n = 114/206). These issues caused 
anxiety for the person with PKU (52%, n = 106/206), anxiety for parent/caregivers (46%, n = 95/206), 
guilt for parent/carers (42%, n = 87/206) and social isolation (42%, n = 87/206). It is important to 
understand the impact of aspartame and legislation such as the sugar tax on people with PKU. 
Policy makers and industry should ensure that the quality of life of people with rare conditions such 
as PKU is not compromised through their action. 
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1. Introduction 
Aspartame, a non-nutritive sweetener, is one of the most widely used artificial sweet-
eners and accounts for 62% of the artificial sweetener market [1]. It is a synthetic dipeptide 
known as N-L-alpha-aspartyl-L-phenylalanine methyl ester (C14H18N2O5) and was ac-
cidentally discovered in 1965 [2,3]. Aspartame is completely hydrolysed to phenylalanine 
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(50%), aspartic acid (40%) and methanol (10%) in the intestinal lumen and is rapidly me-
tabolised by esterases and peptidases [4,5]. It is around 200 times sweeter than sucrose 
and it is estimated that it is added to >6000 foods and drinks [6,7]. Aspartame is approved 
in more than 90 countries and its safety has been evaluated by the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA), as well as by numerous national food safety au-
thorities, including the US Food and Drug Administration (FDA) and the European Food 
Safety Authority (EFSA) [8–10]. Aspartame can be safely consumed by healthy individu-
als, but it has long been recognised as a hazard to individuals with phenylketonuria (PKU) 
and therefore, it should be avoided [11]. The amount of phenylalanine in aspartame con-
taining foods and drinks is not declared on ingredient labels and its impact on metabolic 
control in patients with PKU is not well established [12–14]. 
PKU, an autosomal recessive inherited condition, is caused by mutations in the gene 
encoding phenylalanine hydroxylase. It is estimated to affect 0.45 million individuals 
worldwide, with a global prevalence of 1:23,930 live births [15]. A rigorous lifelong low-
phenylalanine diet is the principal treatment option. It requires the avoidance of high pro-
tein foods such as meat, fish, eggs, lentils, nuts, soya, bread, pasta and cheese. Daily die-
tary phenylalanine intake is calculated, measured and continually controlled according to 
individual tolerance. Eighty per cent of patients tolerate <500 mg/day (10 g natural pro-
tein/day) in order to avoid elevated blood phenylalanine levels. Phenylalanine tolerance 
does vary between patients depending upon the severity of their disorder and the use of 
pharmaceutical treatment options such as sapropterin (synthetic tetrahydrobiopterin 
(BH4), or pegvaliase (phenylalanine ammonium lyase). Sapropterin, an oral drug, is ef-
fective in a subset of BH4 responsive patients with PKU and is usually given as an adjunct 
to dietary treatment [16]. Pegvaliase, delivered by subcutaneous injection, is only licensed 
for adults with blood phenylalanine levels above the European PKU guidelines target 
range [17,18]. Neither pharmaceutical treatment option is available via the National 
Health Service in England. 
The additional scrutiny of checking all food ingredient labels for aspartame in food, 
drinks and drugs intensifies the complexity of management [19]. Aspartame is added to 
a wide variety of foods: low calorie sweeteners, soft drinks (including fizzy drinks, fruit 
squashes/cordials), iced tea, flavoured mineral water, energy drinks, dessert mixes, frozen 
desserts, syrups/dessert sauces, mints, jelly, chewing gum, fruit yogurt, ice lollies, and ice 
creams. It is also added to around 600 pharmaceutical products (both medically pre-
scribed and over the counter) including chewable multivitamins and cough medications. 
According to European law, foods containing aspartame must declare it is added either 
by name or E number (E951) [20]. However, it is not mandatory for manufacturers to state 
the amount of aspartame added to foods, rendering it impossible for people with PKU to 
estimate the phenylalanine intake from this source. 
A further concern in the UK is the Soft Drinks Industry Levy (SDIL) which was in-
troduced by Her Majesty’s Revenue and Customs (HMRC) in 2018 [21]. It is commonly 
referred to as the “sugar tax”. This was devised in response to national concerns about 
rising childhood and teenage obesity and was designed to encourage manufacturers to 
reduce the added sugar content of their drinks. It is a two-tier levy system: including a 
standard tax rate applied to drinks with a sugar content between 5 g and <8 g per 100 mL 
and a higher tax rate applied to drinks with a sugar content ≥8 g per 100 mL. This “sugar 
tax” has been highly effective with at least 50% of manufacturers reducing the sugar con-
tent of their products [22] but it has also led to many manufacturers replacing sugar with 
artificial sweeteners such as aspartame, potentially marginalising the dietary choices of 
patients with PKU. A recent equality risk assessment conducted by the HMRC examining 
the SDIL, stated that they were unaware of any evidence to suggest that the existing warn-
ing on food labels about the presence of aspartame in soft drinks was inadequate for peo-
ple with PKU [23]. 
It is important to understand the impact of added aspartame to foods, drinks and 
medications on people with PKU. This paper aims to examine the frequency of accidental 
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aspartame consumption, the reasons for this, and the challenges associated with avoiding 
aspartame in PKU. 
2. Materials and Methods 
2.1. Study Design 
We performed a cross sectional online survey. Patients with PKU and/or par-
ents/caregivers of a person with PKU were invited to take part in this study. Respondents 
were excluded if they did not reside in the UK. The questionnaire was built in the Online 
Surveys platform (Available online (1st April 2020)): https://www.onlinesurveys.ac.uk 
and placed on the UK National Society for Phenylketonuria (NSPKU) website, with addi-
tional promotion on the NSPKU Twitter and Facebook accounts between April and July 
2020. 
This non-validated questionnaire contained 23 questions; 10 multiple choice (6 of 
which invited additional comments), 8 multiple response, 3 Likert scale and 2 open-ended 
questions. A group of experienced research dietitians from Birmingham Women’s and 
Children’s Hospital (A.P., S.E., A.M.), a colleague at the NSPKU (S.F.) and an expert in 
survey methodology (M.O.) helped develop the survey with a student dietitian from Bir-
mingham City University (E.N.). The questionnaire was also reviewed by lay people to 
ensure its readability. 
2.2. Data Collected 
Demographic information was collected about the type of respondent (patient or par-
ent/caregiver of patients aged ≥18y or <18y), gender of the person with PKU and confir-
mation of residency in the UK. Respondents answered questions about any known con-
sumption of foods, drinks and medications containing aspartame, the frequency this had 
occurred, the reason behind this accidental ingestion and any symptoms this had caused. 
They were also asked about their knowledge and impact of the sugar tax with respect to 
the aspartame content of foods and drinks, and the ease of identifying aspartame on food, 
drinks and medication labels in addition to other challenges of identifying aspartame in 
products. 
Overall themes explored in the survey were: accidental consumption of aspartame in 
food and drinks, accidental consumption of aspartame in medications, the sugar tax, 
drinks choice in different venues, label checking, and the effect of aspartame addition on 
the person with PKU and their family. 
2.3. Statistics 
Quantitative data analysis (inferential and descriptive statistics) was carried out with 
Statistical Package for the Social Sciences (SPSS) version 25 (SPSS Inc., Chicago, IL, USA). 
Multiple response questions were analysed with descriptive statistics only. Statistical sig-
nificance was set at p < 0.05. 
Qualitative data analyses of open-ended responses were carried out in NVIVO v.12 
PRO. The whole survey dataset was imported into NVIVO so that the coding of open-
ended responses could be broken down by survey questions including demographic 
questions. All open-ended responses were analysed thematically. 
2.4. Ethics 
Ethical approval to perform this study (approval number 6085, project title “The ac-
cidental consumption of aspartame in PKU: The experiences of patients and their caregiv-
ers”) was given by Birmingham City University ethics committee. Adults with PKU and 
parents/carers of children and adults with PKU gave their consent at the beginning of the 
online questionnaire. Potential respondents were also advised that data from the survey 
may be published in an anonymized form. If names or hospitals were mentioned in ver-
batim abstracts, these were removed from results presented in this manuscript. 




There were 206 wholly or partially completed questionnaires. Fifty-five per cent (n = 
114) of respondents were adults (18 or over) with PKU or parent/carers of adults with 
PKU and 45% (n = 92) were the parent or carers of children with PKU. 
All respondents were normally residents in the UK. The PKU population described 
by the respondents were: 58% (n = 119) female; 41% (n = 85) male, 1 respondent was ’non-
binary’ and 1 preferred not to say. 
3.1. Accidental Consumption of Aspartame in Food and Drink 
Seventy-four per cent of participants (n = 152/206) said that people with PKU had 
consumed aspartame in a food or drink; 20% (n = 42/206) said they had not and 6% (n = 
12/206) said they did not know. 
Of those who had consumed aspartame by accident/error, just under half (47%, n = 
72/152) said this occurred one to three times; 17% (n = 26/152) said 4 to 6 times and 6% (n 
= 9/152) said that it had occurred 7 to 9 times in the last 3 years. One in ten respondents 
(11%, n = 16/152) said that accidental consumption had occurred 10 times or more. Just 
under one fifth (19%, n = 29/152) of respondents could not recount how often accidental 
consumption had happened. Repeated accidental consumption of aspartame was more 
frequent in adults with PKU than for children (p < 0.0001). In the last 3 years, aspartame 
had been consumed accidentally 1 to 3 times in 79% (n = 42/53) of children and 43% (n = 
30/70) of adults. In contrast, accidental consumption of 4 to 6 times occurred in 31% (n = 
22/70) of adults compared to only 8% (n = 4/53) in children. Females (79%) with PKU were 
more likely to report having consumed aspartame than males (67%) (p = 0.008, Fisher’s 
exact test). Eleven per cent (n = 8/74) of females had 7 to 9 incidents, compared to 0% (0/48) 
of males; 18% (n = 13/74) of females had 10 or more incidents, 3 times the proportion of 
males at 6% (n = 3/48). Patients that answered “don’t know” were excluded. 
The main reasons for accidental consumption of aspartame were manufacturers’ 
changing product recipes (81%, n = 123/152), inability to check the ingredients e.g., drinks 
purchased in a pub or restaurant or from a vending machine (59%, n = 89/152), forgetting 
to check the label (32%, n = 49/152), and picking the wrong product from a shelf when 
shopping (29%, n = 44/152). Other reasons described by the respondents included: served 
the wrong drink in a bar or restaurant, (n = 22), unclear labelling (n = 16), not realising a 
product contained aspartame (n = 11), child unsupervised (n = 6), or other undefined rea-
son (n = 4). 
Examples of the verbatim quotes for the 5 most common themes for accidental aspar-
tame consumption. 
 “Drinks that were previously free from aspartame and fine to drink had their recipe 
changed without seemingly advertising the change. This meant that it was only on 
consumption and tasting the difference from how it used to be that the ingredients 
were checked, and aspartame was found.” 
 “I don’t know how many times I have consumed aspartame, but I know I have. In a 
crowded bar it is hard to request a specific brand name and it is not possible to read 
a label on a multi dispensing tap such as that used by bar staff to add coke or tonic 
to a drink.’’ 
 “I have never seen a lolly with aspartame in before, so I didn’t check it from the ice-
cream man—I checked it only after she had eaten it.’’ 
 “Both my girls have autism. They do not understand consequences and are unable 
to challenge/ask people if the drinks contain aspartame, therefore they will just drink 
what is given to them. They have also picked up the wrong bottles of coke as the 
packaging is not much different at all’’. 
 “Aspartame isn’t required to be listed on alcoholic drinks, therefore it’s hard to know 
if it’s present or not.’’ 
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3.2. Foods/Drinks Involved in Accidental Aspartame Consumption 
The food or drinks containing aspartame most reported to be accidentally consumed 
were fizzy drinks e.g., Coca Cola / lemonade / Irn Bru (68%, n = 103/152), fruit squash/cor-
dials e.g., Robinsons Summerfruit squash (40%, n = 61/152), chewing gum (30%, n = 
46/152), flavoured water (25%, n = 38/152), ready to drink cartons or bottles of juice/squash 
e.g., Strawberry Ribena (23%, n = 35/152), sports drinks e.g., Lucozade/Powerade (21%, n 
= 32/152), alcoholic drinks (19%, n = 29/152), sweets (14%, n = 21/152), jelly (9%, n = 14/152), 
tonic water (7%, n = 11/152), mints (7%, n = 11/152), iced slush drinks (7%, n = 10/152), 
energy drinks e.g., Red Bull (5%, n = 7/152), and table top sweetener e.g., Half-Spoon (3%, 
n = 4/152). 
3.3. Aspartame Consumption of Medically Prescribed and over the Counter Medications 
Twenty-three per cent (n = 48/206) of responders said that people with PKU had been 
prescribed medicines by their doctors that contained aspartame. This was more likely to 
occur in children (30%, n = 28/92) than adults (18%, n = 20/114). 
Seventy-five per cent (n = 36/48) said that medicines were not checked by doc-
tors/pharmacists for aspartame, but it was identified by the person with PKU or their 
carer. Twenty-five per cent (n = 12/48) said they had been advised that it was better to take 
the medicine and not worry about the aspartame content. Four per cent (n = 2/48) of re-
spondents said the amount of phenylalanine from aspartame was checked and the num-
ber of phenylalanine exchanges adjusted accordingly. Thirteen per cent (n = 6/48) gave an 
“other” response including: ‘was given a replacement medication only after they re-
quested for this to happen’, ‘they accepted the medicine even though they knew it con-
tained aspartame’, were ‘refused an alternative medication’, and ‘health professionals 
(dispensing the medication) were unaware of aspartame or PKU’. Although most re-
spondents managed to access an alternative suitable medication, it depended on the pa-
tient or carer first identifying that aspartame was on the list of ingredients on the original 
medication.  
Most respondents (88%, n = 182/206) were aware that some over-the-counter medi-
cines contained aspartame, but 20% (n = 37/182) had consumed aspartame from this 
source. 
Some verbatim extracts about the experiences associated with aspartame in medica-
tions are given below. 
 “I checked the ingredients and found the medicine contained aspartame and had a 
written warning about phenylalanine. I called the doctor who couldn’t think of a dif-
ferent medicine so was told to go to hospital with my child to receive “better care.” 
 “Happens a lot. There have been times when I’ve had to visit several chemists to 
finally get a variation without aspartame. I’ve also asked the GP to issue a script for 
an alternative medicine. It’s always down to the patient to check and Drs and phar-
macists are unaware.’’ 
 “Always been told it’s best to take the medication and get better then worry about 
levels afterwards.’’ 
 “We checked, and it only had a small amount of aspartame and he was very poorly 
and he needed to have it.” 
3.4. “Sugar Tax” 
Most respondents (93%, n =192/206) were aware of the sugar tax. Many respondents 
(85%, n = 164/192) considered the sugar tax made accidental aspartame consumption more 
likely (either much more likely, 59% (n = 114/192) or slightly more likely, 26% (n = 50/192)). 
Eleven per cent (n = 21/192) thought that the sugar tax made no difference to the likelihood 
of accidental consumption of aspartame and just over 3% (n = 6/192) thought that the sugar 
tax had make it less likely. 
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Eighty-nine per cent (n = 170/192) thought the sugar tax led to fewer choices of drinks 
and more than two-thirds (68%, n = 130/192) considered that drink costs increased. More 
than four in 10 respondents said that the sugar tax had caused increased stress for the 
person with PKU and 27%, (n = 52/192) reported greater social isolation. Fifteen per cent 
(n = 29/192) of respondents thought that the tax had led to worse blood phenylalanine 
control for people with PKU. Only 5% (n = 10/192) thought the tax had no effect. ‘Other 
responses’ were commonly expressions of anger, being disheartened or depressed about 
the situation as the sugar tax increased the burden of dietary treatment even more. 
Some examples of verbatim quotes given to the open question responses about the 
impact of the sugar tax: 
 “Drinks are something we can share and enjoy. Drinks that we could enjoy, experi-
ment with, taste and talk about are now becoming less accessible and it has a really 
big impact on us. Sugar is actually one of the few things that we can ingest without 
fear of brain damage, and mental and physical damage.” 
 “My daughter is aware of the higher cost of the non-aspartame products so will often 
choose to go without; thinking about the extra expense to us as parents.” 
 “It has made an already difficult diet even harder to follow and people just think you 
are unhealthy choosing sugar versions and a faddy diet.” 
 “Soul destroying for a person to check every food label/every morsel they put into 
their mouths”. 
3.5. Choice of Drinks in Different Venues 
Respondents stated their dissatisfaction with the supply of drinks in different venues 
(Table 1). This was highest in relation to leisure/sports centres (67%); followed by fast food 
chains (62%) and restaurants (60%). Forty-nine per cent (n = 81/167) were dissatisfied 
(fairly or extremely) with the choice of drinks in hospitals, when people with PKU at-
tended their clinics. Museums, airports, petrol stations and other people’s homes had 
some of the lowest dissatisfaction scores but even for these venues, dissatisfaction is high 
in absolute terms (i.e., there is low satisfaction across all venues and high proportions are 
neutral on most venues). 
Table 1. Satisfaction with the range of drinks across various venues. 
Venue Extremely  Dissatisfied 
Fairly  
Dissatisfied 






Leisure Centre/Sports Centre (n = 165) n = 42 (25%) n = 68 (41%) n = 20 (12%) n = 30 (18%) n = 5 (3%) 
Hospital Clinics (n = 167) n = 41 (25%) n = 40 (24%) n = 32 (19%) n = 47 (28%) n = 7 (4%) 
Fast Food Chains (n = 193) n = 47 (24%) n = 73 (38%) n = 23 (12%) n = 41 (21%) n = 9 (5%) 
Pubs/Bars (n = 188) n = 42 (22%) n = 69 (37%) n = 13 (7%) n = 59 (31%) n = 5 (3%) 
Restaurants (n = 195) n = 41 (21%) n = 76 (39%) n = 26 (13%) n = 46 (24%) n = 6 (3%) 
Schools (n = 123) n = 24 (20%) n = 42 (34%) n = 24 (20%) n = 26 (21%) n = 7 (6%) 
Tourist Attraction e.g., Alton Towers (n = 170) n = 32 (19%) n = 65 (38%) n = 26 (15%) n = 40 (24%) n = 7 (4%) 
Motorway Cafes (n = 170) n = 31 (18%) n = 58 (34%) n = 28 (16%) n = 42 (25%) n = 11 (6%) 
Cafes (n = 197) n = 34 (17%) n = 63 (32%) n = 32 (16%) n = 63 (32%) n = 5 (3%) 
Hotels (n = 170) n = 29 (17%) n = 55 (32%) n = 36 (21%) n = 43 (25%) n = 7 (4%) 
Workplace (n = 113) n = 19 (17%) n = 30 (27%) n = 25 (22%) n = 29 (26%) n = 10 (9%) 
College (n = 64) n = 10 (16%) n = 23 (36%) n = 17 (27%) n = 13 (20%) n = 1 (2%) 
Airports (n = 165) n = 24 (15%) n = 45 (27%) n = 38 (23%) n = 43 (26%) n = 15 (9%) 
Nurseries (n = 73) n = 10 (14%) n = 21 (29%) n = 22 (30%) n = 17 (23%) n = 3 (4%) 
Petrol Stations (n = 180) n = 23 (13%) n = 49 (27%) n = 25 (14%) n = 64 (36%) n = 19 (11%) 
University (n = 65) n = 7 (11%) n = 24 (37%) n = 18 (28%) n = 13 (20%) n = 3 (5%) 
Other People’s Homes e.g., Friends/Family (n = 198) n = 12 (6%) n = 61 (31%) n = 42 (21%) n = 65 (33%) n = 18 (9%) 
Abbreviations: n: number of respondents. This varies considerably and is low for some venues such as ‘university’ and 
‘nurseries’ because these are used predominantly by particular demographic groups and those that did not use them chose 
‘not applicable’ and did not rate. 
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3.6. Label Checking 
Respondents checked labels for food, drinks and medicines most of the time (Table 2). 
Drink labels (96%, n = 196/205) were checked either most of the time or always which is 
higher when compared with food labels (81%, n = 165/203). 
Table 2. Proportion of respondents who check food, drinks and medicine labels. 
 Not at All Rarely Sometimes Most of the Time Always 
Food 
(n = 203) 
n = 1 (<1%) n = 13 (6%) n = 24 (12%) n = 51 (25%) n = 114 (56%) 
Drinks 
(n = 205) 
n = 0 (0%) n = 0 (0%) n = 9 (4%) n = 61 (30%) n = 135 (66%) 
Medicines 
(n = 203) 
n = 8 (4%) n = 18 (9%) n = 18 (9%) n = 30 (15%) n = 129 (64%) 
Food, drinks and medication labels were always checked more often by parents/care-
givers for children. For food, 44% (n = 49/111) of adults or carers of adults always checked 
labels compared with 71% (n = 65/92) of parents/carers of children; for drinks, 56% (n = 
63/113) of adults or carers of adults always checked labels compared with 78% (n = 72/92) 
of parents/carers of children; for medicine, 46% (n = 52/112) of adults or carers of adults 
always checked labels compared with 85% (n = 77/91) of parents/carers of children. On 
average, both adults or carers of adults and carers of children with PKU all checked food, 
drinks and medicines labels for aspartame ‘most of the time’ but carers of children signif-
icantly more so (Table 3). 
Table 3. Mean levels of checking food, drink and medicine labels by age group. 
 
Adult (18 or over) with PKU or 
Parent/Carer of Adult with PKU 
(Mean), n = 114 
Parent or Carer of 
Child with PKU 
(Mean), n = 92 
Total 
(Mean), n = 206 
Mann Whitney 
Test p Value 
Food 4.07 4.58 4.30 p < 0.001 
Drinks 4.50 4.75 4.61 p < 0.001 
Medicines 3.86 4.74 4.25 p < 0.001 
Abbreviations: PKU, Phenylketonuria; n: number of respondents. The mean values re-
late to a scale of 1 to 5 (1 = Not at all; 2 = Rarely; 3 = Sometimes; 4 = Most of the time; 5 = 
Always). 
3.7. Ease of Identifying Aspartame on the Ingredient Label 
A high proportion of respondents reported it was very easy or fairly easy to identify 
aspartame on ingredient labels, 63% (n = 130/205) for food and 65% (n = 133/205) for drinks 
compared to those who had difficulty, 22% (n = 45/205) for food and 23% (n = 48/205) for 
drinks (Table 4). Ease of identification of aspartame on medicines was lower with 46% (n 
= 86/189) reporting it was very easy/fairly easy and 40% (n = 76/189) finding it difficult. 
The number remaining neutral was similar for food, drinks and medication. 
Table 4. Perceived ease of label checking by product type. 
 Very Difficult Fairly Difficult Neither Difficult 
nor Easy 
Fairly Easy Very Easy 
Food (n = 205) n = 11 (5%) n= 34 (17%) n = 30 (15%) n = 89 (43%) n = 41 (20%) 
Drinks (n = 205) n = 8 (4%) n = 40 (20%) n = 24 (12%) n = 80 (39%) n = 53 (26%) 
Medicines (n = 189) n = 19 (10%) n = 57 (30%) n = 27 (14%) n = 57 (30%) n = 29 (15%) 
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3.8. Challenges in Identifying Products which Contain Aspartame 
The biggest challenges identified by respondents are presented in Table 5 in detail. 
Table 5. Challenges in identifying products which contain aspartame. 
Challenges Faced in Identifying if a Food, Drink 
or Medicine Contains Aspartame 
Percentage  
Responses (%) 
Number of Respondents 
per Total Sample (n = 206) 
Difficulties in Identifying Aspartame in Food or 
Drinks Consumed in Restaurants, Pubs, Cafes, 
Vending Machines 
77 158 
Similarities in Appearance of Non-Aspartame and 
Aspartame Containing Products 62 127 
Time Taken to Identify if a Product Contains Aspar-
tame 
56 115 
Unclear Labelling 55 114 
Easy to Make Mistakes 44 91 
Unable to Read the Writing on Food Labels (Writing 
too Small, too Shiny)  
42 87 
Lack of Knowledge about which Products Contain 
Aspartame 
20 42 
Have no Challenges 4 8 
Other 3 7 
Don’t Know <1 1 
Perhaps unsurprisingly, the highest single response category in open-ended re-
sponses about the challenges in identifying aspartame is related to product labelling. This 
was mentioned by nearly half of those who responded to this question. 
Verbatim quotes about the challenges relating to identifying aspartame from labels 
on foods and drinks: 
 “Writing is often too small on supermarket products. Ingredients section often very 
full of text so hard to spot aspartame especially if you are rushing.” 
 “Sometimes I find it tricky to identify aspartame in products due to weird E numbers 
that I have no idea about. Clear labelling of aspartame needs to be on all consumable 
products.’’ 
 “If eating out often, the restaurant staff are reluctant to check labels or are unsure 
about ingredients. Catering size products are not easy for staff to find info. Details of 
ingredients might only be listed on the outer packaging which may have been dis-
carded.” 
Respondents also mentioned that there was no prominent warning about the pres-
ence of aspartame or that this information was not consistently in the same place on pack-
aging. 
 “You are checking the label for aspartame, but the warning is not always in the same 
place”. 
 “The warning text is very small. It inhibits my son’s independence as it’s unrealistic 
to expect a child to check for labelling that is so hard to see. After the sugar tax, pack-
aging changed and removed the easy visual clues that you could rely on to indicate 
that the product had aspartame. As an example, there is now a Coca Cola in a red 
can which has aspartame in it. There are frequently types with aspartame in and 
some without with virtually the same packaging, you have to check everything, and 
this is stressful”. 
Many people commented about the time it takes to check labels. 
 “We are really careful when we check labels, but it takes time, and it is difficult some-
times”. 
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 “I can easily identify aspartame in products with labels, but it is time consuming and 
annoying. I worry that other caregivers, e.g., grandparents, would not be able to. 
There is no labelling in restaurants, so we err on the side of caution and only order 
what we know does not contain aspartame.” 
Some respondents suggested that the warning on packaging should be at least as 
prominent as allergen warnings. 
 “Should be written in bold/special box like allergens.” 
 “Aspartame should be highlighted in a different colour or bold writing as they do for 
peanut allergies.” 
Overall, 74% (n = 152/206) of respondents thought that it would be helpful (fairly or 
extremely) if manufacturers listed the phenylalanine content of food, drink or medicines 
on the label. Only 6% (n = 13/206) were neutral and 20% (n = 41/206) thought it would be 
fairly or extremely unhelpful. 
3.9. Effect of Aspartame on People with PKU and Parents/Carers 
Table 6 gives the percentage of patients that reported each of the stated effects of 
aspartame on patients and parents/caregivers managing PKU. 
Table 6. Reported effects of aspartame on the person with PKU and parent/carer. 
Effects of Aspartame 
Percentage  
Responses (%) 
Number of Respondents per Total Sample 
(n = 206) 
Limits Suitable Drinks in Restaurants/Pubs/Cafes 86 178 
Increases Time taken to do Food Shopping 80 164 
Causes Anxiety for Person with PKU 52 106 
Causes Anxiety for Parent/Carer 46 95 
Causes Guilt for Parent/Carer 42 87 
Causes Social Isolation 42 87 
Person with PKU unable to buy Food or Drinks from 
Shops, Causing Loss of Independence 
40 83 
Have to Keep Food Products Separate in the House be-
tween PKU and Non-PKU Products 
36 75 
Causes Person with PKU to Feel Unwell 33 68 
Causes Guilt for Person with PKU 33 67 
Has no Effect 5 11 
Other 4 8 
Abbreviations: PKU: Phenylketonuria. 
Coding of the open-ended responses about the effect of aspartame showed that the 
top four themes were: feelings of being different, lack of choice, stress or concern and the 
additional time required to check all labels. These issues are illustrated in the following 
verbatim quotes. 
 “It’s very isolating for our son. He feels people see him as fussy until we have to 
explain and even then, they don’t seem to understand.” 
 “Feel bad when I can’t find suitable drinks for my children with PKU, whereas my 
children without PKU can drink whatever they want.” 
 “The PKU diet is heavily restricted and time consuming. Aspartame adds another 
level of restriction and extra time is necessary to check everything before you can buy 
or eat it.” 
 “Checking for aspartame increases stress and anxiety especially when eating out 
which is supposed to be a nice/happy experience.” 




This is the first UK survey to examine the impact of aspartame in food, drinks and 
medications on people with PKU and their caregivers. We found that repeated accidental 
aspartame consumption is common, particularly in adults with PKU. Many respondents 
acknowledged there may be occasions in which aspartame has been inadvertently in-
gested and there were many concerns about the inability to identify its presence in pre-
mixed alcoholic drinks and draft soft drinks in restaurants and bars. 
The most unintentionally consumed aspartame containing items included fizzy 
drinks, fruit squash, cordials, flavoured water, sports drinks and chewing gums. Changes 
to product recipes, selecting the wrong product when shopping, packaging similarities 
between aspartame and non-aspartame containing products, unclear labelling, and diffi-
culties identifying aspartame in drinks purchased from restaurants and pubs were com-
monly identified challenges. This suggests the need for: mandatory ingredient lists for all 
drinks and foods in restaurants, cafes, bars, and vending machines; distinct front of pack-
age labelling when a product recipe has changed; and clear labelling when there are sev-
eral products within a brand range with some containing aspartame and others not (e.g., 
Ribena, Fanta, Tango, Robinsons). There should also be mandatory visible “first glance” 
disclosure of aspartame on packaging. Recently Dutch researchers demonstrated there 
was wide variability in the aspartame content of soft drinks, particularly the same brand 
of soft drinks bought in different countries. They have urged European legislators to en-
force manufacturers to declare the amount of phenylalanine obtained from aspartame on 
food and drink labels, so that individuals with PKU are aware of the phenylalanine con-
tent of foods and drinks [24]. This ‘call for action’ is supported by NSPKU Medical Advi-
sory Panel of dietitians [25]. 
Accidental aspartame consumption due to medications occurred in almost a quarter 
of respondents. Respondents felt there was little awareness or concern about the presence 
of aspartame in medications amongst medical professionals when they prescribed medi-
cation for PKU. Generally, reminders to check prescriptions for aspartame came from pa-
tients/parents’ instruction rather than the GP or pharmacist. Aspartame is commonly used 
as a sugar replacement in antibiotics, chewable tablets and sugar-free liquids. The Euro-
pean PKU guidelines [11,17] recommend that for immediate and short-term treatment of 
infections, if only aspartame containing medicines are available, it may be better to use 
these until aspartame-free medication is sourced rather than leave a person with PKU 
without treatment (for a concurrent illness) as blood phenylalanine levels will rise with 
infection. However, for chronic long-term use of medications, it is better to find alternative 
aspartame free medications. Aspartame can be identified from the list of excipients in the 
medication instruction leaflet or the EMC summary of product characteristics. The 
amount of estimated phenylalanine in a drug may also be listed and can vary from 1 to 25 
mg per dose of medication. There is usually no aspartame warning on the outside pack-
aging of medication and there is no legal obligation to include this [26]. However, it is 
considered important to have mandatory legislation to identify aspartame on the outer 
packaging for people with PKU, otherwise it is challenging to recognize its presence at 
the point of prescription or purchase, and it can be a cause of frustration, inconvenience 
and distress for carers or people with PKU. 
The impact of aspartame in food and drinks on inhibiting socialisation, increasing 
the incumbrance of dietary management and decreasing autonomy for children and teen-
agers is evident. Respondents were particularly dissatisfied with the choice of suitable 
drinks at many venues including fast-food restaurants, leisure centres, tourist venues and 
even hospital clinics. Respondents were angry that waiters/waitresses or sales vendors 
convey little understanding or empathy. They were displeased with the lack of aspartame 
free soft drinks at their hospital, as they considered this to be one location that above all 
others should demonstrate understanding of their condition. For NHS England hospital 
trusts, the Commissioning for Quality and Innovation (CQUIN) offer a financial incentive 
if they provide healthier food and drinks. This includes that 80% of drinks provided/sold 
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must not be sugary. If a hospital trust adheres to the CQUIN for healthy food for NHS 
staff, visitors, and patients, they receive additional funding worth 0.1% of the trust’s over-
all budget [27]. Unfortunately, there are no exceptions for vulnerable groups who are un-
able to tolerate aspartame for medical reasons. 
There was much anger and despondency concerning the sugar tax by the respond-
ents to this survey. Although the sugar tax has been implemented to reduce national over-
weight/obesity, it will not necessarily change unhealthy lifestyle practices. Overall people 
with PKU and their caregivers felt marginalised by this government policy. The sugar tax 
has led to diminished choice of favourite branded drinks and increased the cost of sugar 
containing drinks. For many adults, most available soft drinks in bars now contain aspar-
tame, so the freedom of choice and the ability to enjoy a drink with friends has been with-
drawn, which is hard to endure when there are so many other dietary restrictions to con-
tend with. Many people with PKU have a functional approach to food; they eat for neces-
sity rather than pleasure. However, drinking ‘normal’ branded drinks brought normality 
and choice. Almost 60% of respondents considered that the sugar tax led to more dietary 
errors and 33% felt fatigued or unwell with aspartame consumption, although no other 
information was collected about symptoms. Sugar is one of the few foods that is protein 
free and can be eaten without adversely affecting blood phenylalanine control in PKU. 
Giving adequate energy intake from very low protein sources is essential to meet energy 
requirements and to minimise catabolism that can lead to poor blood phenylalanine con-
trol [11], so sugar is not an ‘unhealthy’ food for people with PKU when eaten in modera-
tion. Although it is unlikely there will be any reversal of the sugar tax, and it is expected 
to be extended to other foods, it is disappointing there is little consideration about the 
impact of the sugar tax on PKU by Public Health England or HMRC. Promoting healthy 
eating and exercise habits in the general population should be the key to solving obesity 
rather than focusing on one food component. Taking a balanced approach, offering many 
healthy choices without compromising the aspartame-free options for people with PKU 
would be a better policy. 
Confusion and regular recipe changes with the addition of aspartame to manufac-
tured foods/drinks affect a child’s ability to self-manage their diet. For foods such as fresh 
meat, fruit and vegetables there is clear guidance on whether these are either permitted 
or forbidden in a low phenylalanine diet; but the ingredients, particularly in popular man-
ufactured sweetened products, may change without notice, adding aspartame, with no 
clear warning to the consumer. It is, therefore, difficult to give pragmatic advice about 
suitable foods and drinks. Aspartame may be added to many children’s foods such as ice 
lollies, soft drinks and iced ‘slush’ drinks that may be purchased from an ice cream van or 
local shop. Consequently, an adult with dietary knowledge should always check the suit-
ability of these foods and the continual checking of food labels is time consuming and 
endless. 
It is incomprehensible that alcoholic beverages with added sweeteners with an alco-
hol by volume content of 1.2% or more, do not have to declare the type of sweetener on 
the label. Moreover, legally no nutrition information needs to be supplied on the label of 
alcohol although appropriate allergen information and relevant quantitative ingredient 
information should be given [28]. This renders it unmanageable for people with PKU to 
be confident that any alcoholic drinks with unnamed sweeteners are safe for consumption. 
Fortunately, it is likely this situation will improve in the next 2 years. A memorandum of 
understanding (Self-regulatory proposal from the European alcoholic beverages sectors 
on the provision of nutrition information and ingredients listing) was presented as a joint 
voluntary commitment to the EU Health Commissioner in June 2019. It committed that 
by the end of 2022 the list of ingredients on alcohol will be provided according to the EU 
1169/2011 law. This law asserts that aspartame should be identified on the list of ingredi-
ents and it must state that it contains a source of phenylalanine [29]. 
There are several limitations to this study. The participants were not randomly se-
lected and individuals without internet access may have been unable to participate. The 
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survey was also promoted on the NSPKU Twitter and Facebook page, meaning partici-
pants were more likely to be NSPKU members who may be more proactive and informed 
about PKU. Therefore, the survey population may not be representative of the entire PKU 
population for which it is estimated that there are around 2000 UK patients in hospital 
follow up. Some surveys were completed by caregivers on behalf of patients with PKU 
and therefore responses to some questions may have been the caregiver’s opinion rather 
than the actual experiences of those with PKU. It may be that aspartame was consumed 
more often but respondents did not realise this. Some respondents were unable to remem-
ber how many times they had consumed aspartame over the three-year period. The sur-
vey was not validated and therefore has not been checked for reliability, however expert 
opinion was used to develop it. This study should be repeated and expanded in the future 
using a validated survey that is piloted and carefully applied by health professionals to 
further improve the accuracy of the data collected. 
5. Conclusions 
It is important that health care professionals and policy makers understand the im-
pact of aspartame and policies affecting the increased use of aspartame such as the sugar 
tax on the lives of people with PKU. Aspartame addition to food and drinks introduces 
social constraints, impacts on metabolic control as well as providing a source of frustra-
tion, guilt and distress to people with PKU and their carers. It is difficult to adhere to the 
PKU diet when all ingredients are not readily declared on labels at the point of purchase 
or issue. This applies to food, drinks, and medicines. It is essential that that industry gives 
clear and ‘front of package’ labelling about aspartame presence and the amount of phe-
nylalanine that the product contains. Manufacturers should also consider using alterna-
tive sweeteners that would be a suitable option for people with PKU. 
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